SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-093302
Filing Date
2020-08-11
Accepted
2020-08-11 16:17:13
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020497d1_10q.htm 10-Q 512757
2 EXHIBIT 31.1 tm2020497d1_ex31-1.htm EX-31.1 8094
3 EXHIBIT 31.2 tm2020497d1_ex31-2.htm EX-31.2 8088
4 EXHIBIT 32.1 tm2020497d1_ex32-1.htm EX-32.1 3791
5 EXHIBIT 32.2 tm2020497d1_ex32-2.htm EX-32.2 3813
  Complete submission text file 0001104659-20-093302.txt   4304600

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20200630.xml EX-101.INS 913845
7 XBRL TAXONOMY EXTENSION SCHEMA ards-20200630.xsd EX-101.SCH 44437
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20200630_cal.xml EX-101.CAL 40180
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20200630_def.xml EX-101.DEF 157480
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20200630_lab.xml EX-101.LAB 400568
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20200630_pre.xml EX-101.PRE 313097
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 201092648
SIC: 2834 Pharmaceutical Preparations